|
Apr 27
|
Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Apr 27
|
Editas Medicine Receives FDA Orphan Drug Designation for EDIT-301 for the Treatment of Sickle Cell Disease
|
|
Apr 26
|
12 Gene Editing Stocks With the Best Long-Term Potential
|
|
Apr 26
|
Earnings Preview: Editas Medicine (EDIT) Q1 Earnings Expected to Decline
|